Towards An Understanding of Neuropsychiatric Manifestations In Fragile X Premutation Carriers
Future Neurology · 31.03.2014 · 9 (2) · 227-239
DOI: 10.2217/fnl.14.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Neurology, online erschienen am 03.03.2014. Verfasst von Aaron D Besterman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of California San Francisco School of Medicine, San Francisco, California 94143 USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIMH NIH HHS, Future Science Group.
Abstract (Originalsprache)
Fragile X-associated disorders (FXD) are a group of disorders caused by expansion of non-coding CGG repeat elements in the fragile X (FMR1) gene. One of these disorders, fragile X syndrome (FXS), is the most common heritable cause of intellectual disability, and is caused by large CGG repeat expansions (>200) resulting in silencing of the FMR1 gene. An increasingly recognized number of neuropsychiatric FXD have recently been identified that are caused by 'premutation' range expansions (55-200). These disorders are characterized by a spectrum of neuropsychiatric manifestations ranging from an increased risk of neurodevelopmental, mood and anxiety disorders to neurodegenerative phenotypes such as the fragile X-associated tremor ataxia syndrome (FXTAS). Here, we review advances in the clinical understanding of neuropsychiatric disorders in premutation carriers across the lifespan and offer guidance for the detection of such disorders by practicing psychiatrists and neurologists.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, University of California San Francisco School of Medicine, San Francisco, California 94143 USA.
- Department of Pediatrics and MIND Institute, University of California Davis, Sacramento, California 95817 USA.
- Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California Davis, Sacramento, California 95817 USA.
Förderung
- NICHD NIH HHS
- NIMH NIH HHS
- Future Science Group
Zitieren
APA
Besterman, A. D., Wilke, S. A., Mulligan, T. E., Allison, S. C., Hagerman, R., Seritan, A. L., & Bourgeois, J. A. (2014). Towards An Understanding of Neuropsychiatric Manifestations In Fragile X Premutation Carriers. Future Neurology, 9(2), 227-239. https://doi.org/10.2217/fnl.14.11
Vancouver
Besterman AD, Wilke SA, Mulligan TE, Allison SC, Hagerman R, Seritan AL, et al. Towards An Understanding of Neuropsychiatric Manifestations In Fragile X Premutation Carriers. Future Neurology. 2014;9(2):227-239. doi:10.2217/fnl.14.11
BibTeX
@article{Besterman2014,
author = {Besterman, Aaron D and Wilke, Scott A and Mulligan, Tua-Elisabeth and Allison, Stephen C and Hagerman, Randi and Seritan, Andreea L and Bourgeois, James A},
title = {Towards An Understanding of Neuropsychiatric Manifestations In Fragile X Premutation Carriers},
journal = {Future Neurology},
year = {2014},
volume = {9},
number = {2},
pages = {227--239},
doi = {10.2217/fnl.14.11}
}
EUVIMED